【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Dyslipidemia Overview 9
Therapeutics Development 10
Pipeline Products for Dyslipidemia – Overview 10
Pipeline Products for Dyslipidemia – Comparative Analysis 11
Dyslipidemia – Therapeutics under Development by Companies 12
Dyslipidemia – Therapeutics under Investigation by Universities/Institutes 16
Dyslipidemia – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Dyslipidemia – Products under Development by Companies 20
Dyslipidemia – Products under Investigation by Universities/Institutes 24
Dyslipidemia – Companies Involved in Therapeutics Development 25
Amgen Inc. 25
Arisaph Pharmaceuticals, Inc. 26
AstraZeneca PLC 27
Biocon Limited 28
Cadila Pharmaceuticals Ltd. 29
Cerenis Therapeutics Holding SA 30
Chong Kun Dang Pharmaceutical Corp. 31
CymaBay Therapeutics, Inc. 32
Daiichi Sankyo Company, Limited 33
Debiopharm International S.A. 34
Dezima Pharma BV 35
Dr. Reddy’s Laboratories Limited 36
Genfit SA 37
GlaxoSmithKline plc 38
Hanmi Pharmaceuticals, Co. Ltd. 39
High Point Pharmaceuticals, LLC 40
Intas Pharmaceuticals Ltd. 41
Jenrin Discovery, Inc. 42
JW Pharmaceutical Corporation 43
Kissei Pharmaceutical Co., Ltd. 44
Kotobuki Pharmaceutical Co., Ltd. 45
Kowa Company, Ltd. 46
Kymab Limited 47
Lipicard Technologies Limited 48
Merck & Co., Inc. 49
Nippon Chemiphar Co., Ltd. 50
Novartis AG 51
Pfizer Inc. 52
Pharmena SA 53
Piramal Enterprises Limited 54
Reviva Pharmaceuticals Inc. 55
Sanofi 56
Takeda Pharmaceutical Company Limited 57
Torrent Pharmaceuticals Limited 58
Zydus Cadila Healthcare Limited 59
Dyslipidemia – Therapeutics Assessment 60
Assessment by Monotherapy Products 60
Assessment by Combination Products 61
Assessment by Target 62
Assessment by Mechanism of Action 64
Assessment by Route of Administration 66
Assessment by Molecule Type 68
Drug Profiles 70
(ezetimibe + rosuvastatin calcium) – Drug Profile 70
(niacin + aspirin) – Drug Profile 71
(pitavastatin + valsartan) – Drug Profile 72
(rosuvastatin calcium + ezetimibe) – Drug Profile 73
(statin + niacin + aspirin) – Drug Profile 74
4655-K09 – Drug Profile 75
anacetrapib – Drug Profile 76
ARI-3037MO – Drug Profile 78
AZ-12260493 – Drug Profile 80
BioE-1115 – Drug Profile 81
bococizumab – Drug Profile 82
BSN-852 – Drug Profile 83
C-24 – Drug Profile 84
C-3 – Drug Profile 85
Centatin – Drug Profile 86
CKD-519 – Drug Profile 87
Debio-0930B – Drug Profile 88
DEZ-001 – Drug Profile 89
DF-461 – Drug Profile 90
DGAT-1 – Drug Profile 91
DRL-17822 – Drug Profile 92
evolocumab – Drug Profile 93
GFT-505 – Drug Profile 96
GSK-2041706 – Drug Profile 99
HCP-1105 – Drug Profile 100
HCP-1305 – Drug Profile 101
HDL Receptor Enhancer – Drug Profile 102
HPP-593 – Drug Profile 103
INSUPR-001 – Drug Profile 104
JD-5037 – Drug Profile 105
K-312 – Drug Profile 106
K-877 – Drug Profile 107
KT6-971 – Drug Profile 108
KTA-439 – Drug Profile 109
KY-1020 – Drug Profile 110
LP-071 – Drug Profile 111
LT-5421 – Drug Profile 112
LT-5423 – Drug Profile 113
MAT-9001 – Drug Profile 114
MBX-8025 – Drug Profile 115
MGL-3196 – Drug Profile 117
NC-2400 – Drug Profile 119
ND-630 – Drug Profile 120
ND-654 – Drug Profile 121
P-7435 – Drug Profile 122
Peroxibrate – Drug Profile 123
pitavastatin CR – Drug Profile 124
Recombinant ApoE4 for Dyslipidemia – Drug Profile 125
RP-17000 – Drug Profile 126
Small Molecule 1 to Inhibit Diacylglycerol Acyltransferase Inhibitor for Obesity, Dyslipidemia and Type 2 Diabetes – Drug Profile 127
Small Molecule 2 to Inhibit Diacylglycerol Acyltransferase Inhibitor for Obesity Dyslipidemia and Type 2 Diabetes – Drug Profile 128
Small Molecule to Activate Lipoprotein Lipase for Dyslipidemia – Drug Profile 129
Small Molecule to Inhibit Farnesoid X Receptor for Dyslipidemia – Drug Profile 130
Small Molecules for Dyslipidemia and Hypertriglyceridemia – Drug Profile 131
Small Molecules to Inhibit DGAT-1 for Dyslipidemia and Obesity – Drug Profile 132
Small Molecules to Inhibit DGAT-1 for Metabolic Disorders – Drug Profile 133
Small Molecules to Inhibit Endothelial Lipase for Dyslipidemia – Drug Profile 134
SPX-100 – Drug Profile 135
SPX-8522876 – Drug Profile 136
Synthetic Peptides for Dyslipidemic and Vascular Disorders – Drug Profile 137
TAP-311 – Drug Profile 138
TRC-210258 – Drug Profile 139
TRIA-662 – Drug Profile 140
VK-0214 – Drug Profile 142
ZLN-005 – Drug Profile 143
ZLN-024 – Drug Profile 144
ZYH-7 – Drug Profile 145
ZYT-1 – Drug Profile 146
Dyslipidemia – Recent Pipeline Updates 147
Dyslipidemia – Dormant Projects 168
Dyslipidemia – Discontinued Products 175
Dyslipidemia – Product Development Milestones 180
Featured News & Press Releases 180
Appendix 194
Methodology 194
Coverage 194
Secondary Research 194
Primary Research 194
Expert Panel Validation 194
Contact Us 195
Disclaimer 195
【レポート販売概要】
■ タイトル：脂質異常症(Dyslipidemia)の治療薬パイプライン動向（2015年上半期版）■ 英文：Dyslipidemia - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6020IDB
■ 調査対象地域：グローバル
- 世界の航空宇宙用プラスチック市場動向（2014-2018）TechNavio's analysts forecast the Global Aerospace Plastics market to grow at a CAGR of 8.04 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growth and development of the Aviation industry. The Global Aerospace Plastics market has also been witnessing the emergence of composites and nanocomposites. However, the increasing fracture and failure iss …
- モーターコントロールセンター（MCC）の世界市場動向・予測（～2021）The global motor control centers market is projected to grow at a CAGR of 5.3% from 2016 to 2021, to reach a size of USD 5.83 Billion by 2021. This growth is attributed to increasing demand for industrial automation and growing concerns for energy efficiency across major industries. On the basis of end-user industry, the report segments motor control centers market into commercial and industrial. …
- ニードルフリーIVコネクターの世界市場2018-2022About Needle-Free IV Connectors Needle-free IV connectors are used to connect administration sets, syringes, and IV catheters. Technavio’s analysts forecast the global needle-free IV connectors market to grow at a CAGR of 9.56% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the global needle-free IV connectors market for 2018- …
- グリコールの世界市場分析：用途別（自動車、HVAC、テキスタイル、航空、医療、パイプライン補修繊維･樹脂、食品加工）、地域別、セグメント予測、2014-2025The global glycols market value is anticipated to exceed USD 47.2 billion by 2025, according to a new report by Grand View Research, Inc. The rising HVAC demand for advanced and high quality heating and cooling systems is expected to be a key factor steering the growth in the coming years. Glycols include ethylene, propylene and its derivatives are predominately used in the automotive sector as en …
- 肺動脈塞栓症(Pulmonary Embolism)：治療薬開発パイプライン動向（2015年上半期版）Pulmonary Embolism - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Embolism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pulmonary Embolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mecha …
- 痙性脳性麻痺治療のグローバル臨床試験動向（2014年下半期）Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Cerebral Palsy. It includes an overview of the trial numbers and …
- 世界のBYOD（Bring Your Own Device）市場：mSecurity/企業BYOD/DaaS/モバイルアプリケーションBYOD/mSaaS/VDI BYODThe BYOD market has been growing exponentially over the past few years. In 2014, the technology is poised to see substantial uptake due to the growing number of connected devices, and the increasing acceptance of BYOD policy in enterprises around the globe. Consumer devices such as smartphones, tablets, wearable gadgets and eReaders are currently enjoying high adoption rates across the globe. With …
- 電気生理学アブレーション用カテーテル（医療機器）のグローバル市場（2012-2018）Global Electrophysiology (EP) Ablation Catheters sector is projected to reach US$341 million by 2016. The North America accounts for nearly 34% (2015) of the global share while Europe claims approximately 30% (2018). Asia-Pacific is the fastest growing region with a CAGR of 9.2% driving a market value of US$83 million by 2015. On a global scale, projections for Radiofequency (RF) EP Ablation Cathe …
- ビリルビン血液検査の世界市場2019-2023About this market The technological advances are likely to foster the bilirubin blood test market growth during the forthcoming years. Market players are offering products with improved features and specific manufacturing standards for creating a mark in the market. The modern products from the market players are allowing vendors in retaining their existing consumers and attracting prospective con …
- 表皮水疱症治療薬の世界市場2019-2023About this market Despite the significant research activities undertaken over the past several decades, a promising treatment with very few side effects is not yet developed for the treatment of epidermolysis bullosa. Hence, various government and private organizations are releasing funds to advance the research on the development of promising therapeutics that can demonstrate better safety and ef …
- 偽装テクノロジの世界市場予測（～2021年）The rise in Advanced Persistent Threats (APTs) and zero-day attacks trends is expected to drive the deception technology marketThe deception technology market size is estimated to grow from USD 1.04 billion in 2016 to USD 2.09 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 15.1%. The deception technology market is driven by factors such as rise in Advanced Persistent Threats (APTs) an …
- 脳梗塞(脳軟化症)(Cerebral Infarction (Brain Infarction))：治療薬開発パイプライン動向（2015年上半期版）Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2015’, provides an overview of the Cerebral Infarction (Brain Infarction)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with compa …
- 世界の自動車サラウンドビューシステム市場2015The Global Automotive Surround-view Systems Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Surround-view Systems industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Surround-view Systems market analysis is provided for the international marke …
- 自動車用カムレス型のエンジンの世界市場2017-2021About Automotive Camless Engine An automotive camless engine is defined as an engine configuration wherein the poppet valves are operated using pneumatic, electrohydraulic, or electromagnetic actuator systems instead of conventional cams. The intake or exhaust valves are operated using the camless arrangement of the camshaft, which incorporates the use of springs or other means. This type of engin …
- マネージド型セキュリティサービスの世界市場2016-2020About Managed Security Services Managed security services are the services provided by an outsourced managed security service provider to maintain information security and network security. This service is provided either on the client's premises or it is outsourced to a company that specializes in networking and information system security. Managed security service providers (MSSPs) offer managed …
